Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan on Insulin Secretion and Interaction with DPP4 Inhibitors in Type 2 Diabetes
NCT02312375Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fimasartan in type 2 diabetes mellitus (T2DM) and hypertension (HTN), sponsored by Seoul National University Hospital. Primary endpoint: Insulinogenic index at 16 weeks. Started Mar 2015; status: completed.
02
Drugs
fimasartan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT02312375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312375.